Transmissible Spongiform Encephalopathies Advisory Committee > October 29, 2010: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Transcript

October 29, 2010: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Transcript


October 29, 2010
The Holiday Inn Gaithersburg
2 Montgomery Village Avenue
Gaithersburg, Maryland


This transcript has not been edited or corrected, but appears as received from the commercial transcription service. Accordingly, the Food and Drug Administration makes no representation as to its accuracy.

Proceedings by:

CASET Associates, Ltd.
Fairfax, Virginia 22030
caset@caset.net

TABLE OF CONTENTS

Opening Remarks, Chair, TSEAC 1
Statement of Conflicts of Interest 1
Informational Presentations: FDA's Geographic Donor
Deferral Policy to reduce the Possible Risk of Trans- mission of Creutzfeldt-Jakob Disease and Variant
Creutzfeldt-Jakob Disease by Blood and Blood Products and Human Cells, Tisues and Cellular and Tissue-based Products

full-text (large size):
Transmissible Spongiform Encephalopathies Advisory Committee > October 29, 2010: Transmissible Spongiform Encephalopathies Advisory Committee Meeting Transcript